Computer-based Skin Aging Simulation for Skin Cancer Prevention

December 14, 2021 updated by: University Hospital, Basel, Switzerland

Computer-based Skin Aging Simulation for Skin Cancer Prevention: A Pilot Study

This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In young adulthood an increasing UV-exposure often starts because of the belief that tanning increases attractiveness]. Raising awareness and educating students and adults regarding practices for skin cancer prevention are critical since skin cancer is increasing rapidly worldwide. Skin cancer preventive interventions for adolescents are needed to improve their motivation for sun safety behavior. This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Basel, Switzerland, 4031
        • Department of Dermatology, University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Young healthy female volunteers aged 18-35 years, e.g. medical students of the University Basel, who do not have any skin diseases requiring medical therapy

Description

Inclusion Criteria:

  • healthy female volunteers
  • written,Institutional Review Board (IRB)/ Independent Ethics Committee (IEC)-approved informed consent.

Exclusion Criteria:

  • skin diseases requiring medical therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual analogue scale (VAS) score regarding importance of UV- protection
Time Frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding importance of UV- protection (0 = not important; 10 = extremly important)
before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding rating of personal exposure to UV radiation
Time Frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding rating of personal exposure to UV radiation (0 = no exposure; 10 = very high exposure)
before and after the skin aging simulation (each scoring session will take about 15-20 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire asking for reduction of UV- exposure (yes/no)
Time Frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Questionnaire asking for reduction of UV- exposure (yes/no)
after the skin aging simulation (each scoring session will take about 15-20 minutes)
Questionnaire asking for intensification of UV protection measures (yes/ no)
Time Frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Questionnaire asking for intensification of UV protection measures (yes/ no)
after the skin aging simulation (each scoring session will take about 15-20 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 9, 2021

Primary Completion (ACTUAL)

March 19, 2021

Study Completion (ACTUAL)

March 19, 2021

Study Registration Dates

First Submitted

August 25, 2020

First Submitted That Met QC Criteria

August 25, 2020

First Posted (ACTUAL)

August 31, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 15, 2021

Last Update Submitted That Met QC Criteria

December 14, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Req-2020-00963; sp20Maul3

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Aging

Clinical Trials on artificial intelligence-based skin aging simulation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe